NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Obesity & Diabetes Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Obesity & Diabetes Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Obesity and Diabetes Cell Biology



New obesity and diabetes cell biology study results reported from Institute of Molecular Biotechnology



December 10th, 2007

Investigators publish new data in the report 'Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes.' "Type-2 diabetes results from the development of insulin resistance and a concomitant impairment of insulin secretion. Recent studies place altered mitochondrial oxidative phosphorylation (OxPhos) as an underlying genetic element of insulin resistance," scientists writing in the journal Cell report.

"However, the causative or compensatory nature of these OxPhos changes has yet to be proven. Here, we show that muscle-and liver-specific AIF ablation in mice initiates a pattern of OxPhos deficiency closely...


Source: Obesity & Diabetes Week (2007-12-10)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login